Diversity, Equity and Inclusion

2. ___________ trials equals better science, better health outcomes, better trust.
4. How can we each __________ to more inclusive research?
8. A benefit of DEI in clinical trials is that it reduces _______ disparities.
10. The degree to which people with different identities are welcomed, invited to participate fully, and leveraged in a given setting.
11. Acronym for Diversity, Equity and Inclusion.
14. ____________ ________are the foundation of medical progress.
16. DEI matters in clinical trials because different populations respond differently to _________.
17. The presence of differences in identities, both visible and invisible, among a group, for example gender, ethnicity, race, sexual orientation, religion.
18. Some key challenges have been ________, cultural and socioeconomic barriers.

1. DEI has increased black and ______ representation in COVID-19 vaccine trials.
3. __________that enables remote participation, widening access.
5. Looking ahead regulatory agencies now require reporting on ______ _________.
6. A key challenge of DEI in clinical trials has been the low participation from _______ groups.
7. DEI is essential for equitable, effective and ___________ clinical research.
9. A strategy to improve DEI in clinical trials has been flexible ______ ________ including transportation, childcare, etc.
12. The quality of being fair and just, especially in a way that takes account of and seeks to address existing inequalities.
13. Trial teams must prioritize by carefully designing and conducting trials that include and represent _______ patient populations.
15. Inclusive trials improve __________ and effectiveness.